Current real-world data at a glance

The better the efficacy of a systemic treatment, the higher the patient satisfaction, especially if the risk-benefit balance is favorable. This plausible correlation is impressively underpinned by current findings from psoriasis research. In view of the wide range of treatments available, it is becoming increasingly important to select therapies that are tailored to individual patient characteristics. Analyses of the PsoBest registry and data sets from the “Adelphi Real World PsO Disease Specific Program” as well as other registry studies and survey data provide valuable insights in this regard.